Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]

Background In 2021 we launched the BronchStart study, which collected information on 17,899 presentations in children with serious respiratory tract infections following the release of lockdown restrictions. Our study informed the Joint Committee on Vaccination and Immunisation’s decision to recomme...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark D. Lyttle, Helen Groves, Thomas C. Williams, Simon B. Drysdale, Ian Sinha, Xinxue Liu, Steve Cunningham, Dalia Iskander, Abigail Maxwell-Hodkinson, Shaun O'Hagan, Olivia V. Swann, Chengetai D. Mpamhanga, Damian Roland, Thomas Waterfield, Robin Marlow
Format: Article
Language:English
Published: Wellcome 2024-12-01
Series:Wellcome Open Research
Subjects:
Online Access:https://wellcomeopenresearch.org/articles/6-120/v4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850250823048626176
author Mark D. Lyttle
Helen Groves
Thomas C. Williams
Simon B. Drysdale
Ian Sinha
Xinxue Liu
Steve Cunningham
Dalia Iskander
Abigail Maxwell-Hodkinson
Shaun O'Hagan
Olivia V. Swann
Chengetai D. Mpamhanga
Damian Roland
Thomas Waterfield
Robin Marlow
author_facet Mark D. Lyttle
Helen Groves
Thomas C. Williams
Simon B. Drysdale
Ian Sinha
Xinxue Liu
Steve Cunningham
Dalia Iskander
Abigail Maxwell-Hodkinson
Shaun O'Hagan
Olivia V. Swann
Chengetai D. Mpamhanga
Damian Roland
Thomas Waterfield
Robin Marlow
author_sort Mark D. Lyttle
collection DOAJ
description Background In 2021 we launched the BronchStart study, which collected information on 17,899 presentations in children with serious respiratory tract infections following the release of lockdown restrictions. Our study informed the Joint Committee on Vaccination and Immunisation’s decision to recommend the introduction maternal respiratory syncytial virus (RSV) vaccination, which was introduced in the United Kingdom in August/September 2024. Study question We modified our original protocol to conduct a United Kingdom-wide assessment of maternal vaccination against RSV. Methods and likely impact We will conduct a multi-centre study, utilising the PERUKI network used in the original BronchStart study, to assess the effectiveness of maternal vaccination using a test-negative study design. We will gather detailed clinical information on children admitted with bronchiolitis in the post-RSV vaccination era, and understand possible reasons for incomplete vaccine uptake.
format Article
id doaj-art-90cef1f8bbcc4de7804c48e38eef2e45
institution OA Journals
issn 2398-502X
language English
publishDate 2024-12-01
publisher Wellcome
record_format Article
series Wellcome Open Research
spelling doaj-art-90cef1f8bbcc4de7804c48e38eef2e452025-08-20T01:58:05ZengWellcomeWellcome Open Research2398-502X2024-12-01610.12688/wellcomeopenres.16778.425971Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]Mark D. Lyttle0https://orcid.org/0000-0002-8634-7210Helen Groves1Thomas C. Williams2https://orcid.org/0000-0002-3866-1344Simon B. Drysdale3Ian Sinha4Xinxue Liu5Steve Cunningham6https://orcid.org/0000-0001-7342-251XDalia Iskander7Abigail Maxwell-Hodkinson8Shaun O'Hagan9Olivia V. Swann10https://orcid.org/0000-0001-7386-2849Chengetai D. Mpamhanga11Damian Roland12https://orcid.org/0000-0001-9334-5144Thomas Waterfield13Robin Marlow14Faculty of Health and Applied Sciences, University of the West of England, Bristol, UKWellcome-Wolfson Institute for Experimental Medicine at Queen’s University Belfast, Belfast, UKInstitute of Genetics and Cancer, University of Edinburgh, Edinburgh, UKOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UKUniversity of Liverpool, Liverpool, UKOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UKCentre for Inflammation Research, University of Edinburgh, Edinburgh, UKDepartment of Anthropology, University College London, London, UKUniversity of Liverpool Medical School, Liverpool, UKWellcome-Wolfson Institute for Experimental Medicine at Queen’s University Belfast, Belfast, UKDepartment of Child Life and Health, University of Edinburgh, Edinburgh, UKDepartment of Child Life and Health, University of Edinburgh, Edinburgh, UKPaediatric Emergency Medicine Leicester Academic (PEMLA) Group, Leicester Royal Infirmary, Leicester, UKWellcome-Wolfson Institute for Experimental Medicine at Queen’s University Belfast, Belfast, UKEmergency Department, Bristol Royal Hospital for Children, Bristol, UKBackground In 2021 we launched the BronchStart study, which collected information on 17,899 presentations in children with serious respiratory tract infections following the release of lockdown restrictions. Our study informed the Joint Committee on Vaccination and Immunisation’s decision to recommend the introduction maternal respiratory syncytial virus (RSV) vaccination, which was introduced in the United Kingdom in August/September 2024. Study question We modified our original protocol to conduct a United Kingdom-wide assessment of maternal vaccination against RSV. Methods and likely impact We will conduct a multi-centre study, utilising the PERUKI network used in the original BronchStart study, to assess the effectiveness of maternal vaccination using a test-negative study design. We will gather detailed clinical information on children admitted with bronchiolitis in the post-RSV vaccination era, and understand possible reasons for incomplete vaccine uptake.https://wellcomeopenresearch.org/articles/6-120/v4COVID-19 Respiratory Syncytial Virus Bronchiolitis Infants Children Palivizumabeng
spellingShingle Mark D. Lyttle
Helen Groves
Thomas C. Williams
Simon B. Drysdale
Ian Sinha
Xinxue Liu
Steve Cunningham
Dalia Iskander
Abigail Maxwell-Hodkinson
Shaun O'Hagan
Olivia V. Swann
Chengetai D. Mpamhanga
Damian Roland
Thomas Waterfield
Robin Marlow
Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]
Wellcome Open Research
COVID-19
Respiratory Syncytial Virus
Bronchiolitis
Infants
Children
Palivizumab
eng
title Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]
title_full Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]
title_fullStr Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]
title_full_unstemmed Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]
title_short Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” [version 4; peer review: 3 approved, 1 approved with reservations]
title_sort update to study pre protocol for bronchstart the impact of the covid 19 pandemic on the timing age and severity of respiratory syncytial virus rsv emergency presentations a multi centre prospective observational cohort study version 4 peer review 3 approved 1 approved with reservations
topic COVID-19
Respiratory Syncytial Virus
Bronchiolitis
Infants
Children
Palivizumab
eng
url https://wellcomeopenresearch.org/articles/6-120/v4
work_keys_str_mv AT markdlyttle updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT helengroves updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT thomascwilliams updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT simonbdrysdale updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT iansinha updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT xinxueliu updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT stevecunningham updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT daliaiskander updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT abigailmaxwellhodkinson updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT shaunohagan updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT oliviavswann updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT chengetaidmpamhanga updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT damianroland updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT thomaswaterfield updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations
AT robinmarlow updatetostudypreprotocolforbronchstarttheimpactofthecovid19pandemiconthetimingageandseverityofrespiratorysyncytialvirusrsvemergencypresentationsamulticentreprospectiveobservationalcohortstudyversion4peerreview3approved1approvedwithreservations